第４・放射線科

Medicine and Dentistry

1. Computer Assisted Tomography 100%
2. Vocal Folds 58%
3. Multidetector Computed Tomography 50%
4. Vestibule of the Ear 33%
5. Morphology 33%
6. Volunteer 33%
7. Epiglottis 28%
8. Cross Sectional Study 25%
9. Plummer-Vinson Syndrome 24%
10. Single-Photon Emission Computed Tomography 20%
11. Hyoid Bone 20%
12. Soft Palate 20%
13. Age Groups 19%
14. Pharynx 17%
15. Ligation 17%
16. Four Dimensional Computed Tomography 16%
17. Velopharyngeal Inadequacy 16%
18. Pentetic Acid 16%
19. Interstitial Lung Disease 16%
20. Malignant Pleural Effusion 16%
21. Pleurodesis 16%
22. Whole Body Radiation 16%
23. Clinical Trial 16%
24. Induction Chemotherapy 16%
25. Bone Marrow Transplantation 16%
26. Pathologist 16%
27. Middle Age 16%
28. Maxillary Sinus 16%
29. Piriform Sinus 16%
30. Bone Defect 16%
31. Mesenteric Vein Thrombosis 16%
32. Tongue 16%
33. Eustachian Tube 16%
34. Speech Production 16%
35. Osteonecrosis of the Jaw 16%
36. Cleft Palate 16%
37. Superior Mesenteric Vein 16%
38. Galactose 16%
39. Technetium-99 16%
40. Computational Fluid Dynamics 16%
41. Cleft 16%
42. Imaging Agent 16%
43. Asialoglycoprotein Receptor 16%
44. Hepatectomy 16%
45. Health Care Cost 16%
46. Nuclear Medicine 16%
47. Cyberknife 16%
48. Dose Distribution 16%
49. Radiation Therapy 16%
50. Human Serum Albumin 16%
51. X-Ray Computed Tomography 16%
52. Head Movement 13%
53. Scintigraphy 12%
54. Hepatocyte 12%
55. Hematologic Malignancy 11%
56. Nasal Cavity 11%
57. Base 11%
58. Diseases 9%
59. Volume CT 9%
60. Nasal Septum 8%
61. Oropharynx 8%
62. Weakness 8%
63. Lifespan 8%
64. Swallowing Function 8%
65. Lobectomy 8%
66. Liver Cancer 8%
67. Education 8%
68. Cartilage 8%
69. Cell Surface 8%
70. Hepatocellular Carcinoma 8%
71. Hypopharynx 6%
72. Radiation Treatment 6%
73. Survival Rate 5%
74. Graft Versus Host Reaction 5%
75. Nasal Congestion 5%
76. Standardized Uptake Value 5%
77. Epidermal Growth Factor Receptor Kinase Inhibitor 5%

Keyphrases

1. Computed Tomography 37%
2. Eustachian Tube 33%
3. Multi-slice Spiral CT 33%
4. 320-detector Row CT 17%
5. Treatment Outcome 17%
6. Cyber Knife 16%
7. Precision Radiotherapy 16%
8. Superior Mesenteric Vein Thrombosis 16%
9. Four-dimensional Computed Tomography 16%
10. Laryngeal Closure 16%
11. Dynamic Area 16%
12. Tongue Protrusion 16%
13. Swallowing Evaluation 16%
14. Closure Function 16%
15. Malignant Pleural Effusion 16%
16. Chemotherapy 16%
17. Primary Central Nervous System Lymphoma (PCNSL) 16%
18. Medication-related Osteonecrosis of the Jaw (MRONJ) 16%
19. Disease Detection 16%
20. Morphological Detection 16%
21. Bone Marrow Transplantation 16%
22. Primary Malignant 16%
23. Kinematic Analysis 16%
24. Radiotherapy Treatment 16%
25. Hyoid 16%
26. Quantitative Value 16%
27. Dose Distribution 16%
28. Sinus Anatomy 16%
29. Tongue-hold Swallow 16%
30. Pleurodesis 16%
31. Age-related Changes 16%
32. Sniffing 16%
33. Central Nervous System 16%
34. Total Body Irradiation 16%
35. Single-photon Emission Computed Tomography (SPECT) 16%
36. Secondary Malignancy 16%
37. CyberKnife 16%
38. Beam System 16%
39. Clinical Evaluation 16%
40. Aerosol Transfer 16%
41. Normal Swallowing 16%
42. CT Scanner 16%
43. Radiation Exposure 16%
44. Pediatric Patients 16%
45. Interstitial Lung Disease 16%
46. Bolus Viscosity 16%
47. Combined Modality Therapy 16%
48. Velopharyngeal Closure 16%
49. Area Detector Computed Tomography 16%
50. Posterior Pharyngeal Wall 16%
51. Malignant Lymphoma 16%
52. Epiglottic 13%
53. Homogeneity Index 13%
54. TrueBeam 13%
55. Velopharyngeal Insufficiency 12%
56. Nasopharyngoscopy 11%
57. True Vocal Cord 10%
58. Pharyngoesophageal Segment 10%
59. CT Images 9%
60. Adult Group 8%
61. Cartilage 8%
62. Schoolchildren 8%
63. Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitor (EGFR-TKI) 8%
64. Education Work 8%
65. Cleft Palate 8%
66. Saliva 7%
67. Virtual Target 6%
68. Arytenoid 6%
69. Metastatic Liver Cancer 6%
70. Multi-slice Computed Tomography 6%
71. Airway Protection 6%
72. Radiation Therapy 6%
73. Poor Prognosis 6%
74. Submucous 6%
75. Cross-sectional Area 6%
76. Hyperfractionated 5%
77. Maintenance Procedures 5%
78. Bowel Wall 5%
79. Gas Collection 5%
80. Fluid Collection 5%
81. Superior Mesenteric Vein 5%
82. Osteonecrosis of the Jaw 5%
83. Consecutive Days 5%
84. Donor Cells 5%
85. First Remission 5%
86. Second Remission 5%
87. Patients with Hematological Malignancies 5%
88. Cumulative Survival Rate 5%
89. Hematological Malignancies 5%
90. Treatment Methods 5%
91. Standardized Uptake Value 5%
92. HLA Matching 5%
93. Bowel 5%
94. Matched Unrelated 5%
95. Early Diagnosis 5%
96. Ascites 5%
97. Induction Chemotherapy 5%
98. Morphological Changes 5%
99. Lymphoma Patients 5%
100. Tongue 5%